Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

iPSC technology‐based regenerative therapy for diabetes

13 Jun 2017

Abstract excerpt

The directed differentiation of human pluripotent stem cells, such as embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), into pancreatic endocrine lineages has been vigorously examined by reproducing the in vivo developmental processes of the pancreas. Recent advances in this research field have enabled the generation from hESCs/iPSCs of functionally mature β-like cells in vitro that show...

Topics

Join the communities discussing this publication.

Pancreatic function and diabetes
Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28609558
DOI: 10.1111/jdi.12702

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

iPSC technology‐based regenerative therapy for diabetesPMID 28609558Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cellsSemantic proximity Read ↗

Stem Cells to Pancreatic β-Cells: New Sources for Diabetes Cell TherapySemantic proximity Read ↗

Potential of pluripotent stem cells for diabetes therapy.Semantic proximity Read ↗

Applications of iPSC-derived beta cells from patients with diabetesSemantic proximity Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

Converting human pluripotent stem cells into β-cells: recent advances and future challengesSemantic proximity Read ↗

Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.Semantic proximity Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

Pancreatic Beta Cell Differentiation From Human Pluripotent Stem CellsSemantic proximity Read ↗

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.